Hawkins (NASDAQ:HWKN) Receives “Buy” Rating from BWS Financial

Hawkins (NASDAQ:HWKN)‘s stock had its “buy” rating restated by equities researchers at BWS Financial in a note issued to investors on Thursday,Benzinga reports. They currently have a $200.00 target price on the specialty chemicals company’s stock. BWS Financial’s price objective suggests a potential upside of 44.50% from the company’s current price.

A number of other equities research analysts have also recently commented on HWKN. Weiss Ratings cut shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 12th. Zacks Research upgraded shares of Hawkins from a “strong sell” rating to a “hold” rating in a research report on Friday, January 2nd. Two equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $162.50.

Hawkins Stock Performance

Shares of NASDAQ HWKN traded down $15.34 during trading on Thursday, reaching $138.41. 452,212 shares of the company traded hands, compared to its average volume of 132,140. The firm’s fifty day simple moving average is $144.14 and its 200 day simple moving average is $156.57. The stock has a market cap of $2.89 billion, a P/E ratio of 34.86, a PEG ratio of 2.38 and a beta of 0.86. Hawkins has a 12-month low of $98.30 and a 12-month high of $186.15. The company has a current ratio of 2.43, a quick ratio of 1.49 and a debt-to-equity ratio of 0.53.

Hawkins (NASDAQ:HWKN) last issued its earnings results on Wednesday, January 28th. The specialty chemicals company reported $0.72 EPS for the quarter, missing analysts’ consensus estimates of $0.75 by ($0.03). The company had revenue of $244.08 million during the quarter, compared to analysts’ expectations of $252.51 million. Hawkins had a return on equity of 17.42% and a net margin of 7.95%. As a group, research analysts anticipate that Hawkins will post 4 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Hawkins news, VP Drew M. Grahek bought 1,587 shares of the stock in a transaction on Monday, November 3rd. The shares were bought at an average price of $126.34 per share, with a total value of $200,501.58. Following the purchase, the vice president directly owned 39,640 shares in the company, valued at $5,008,117.60. This trade represents a 4.17% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 4.10% of the company’s stock.

Hedge Funds Weigh In On Hawkins

A number of institutional investors and hedge funds have recently bought and sold shares of HWKN. Salomon & Ludwin LLC acquired a new stake in Hawkins in the 3rd quarter valued at about $27,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new position in shares of Hawkins during the 2nd quarter worth approximately $31,000. First Horizon Corp purchased a new stake in shares of Hawkins in the third quarter valued at approximately $34,000. Sound Income Strategies LLC purchased a new stake in shares of Hawkins in the fourth quarter valued at approximately $34,000. Finally, Aster Capital Management DIFC Ltd increased its holdings in shares of Hawkins by 62.2% in the third quarter. Aster Capital Management DIFC Ltd now owns 300 shares of the specialty chemicals company’s stock valued at $55,000 after purchasing an additional 115 shares during the last quarter. 69.71% of the stock is currently owned by institutional investors and hedge funds.

Hawkins News Roundup

Here are the key news stories impacting Hawkins this week:

• Positive Sentiment: Board declared a quarterly cash dividend of $0.19 per share (payable Feb. 27; record date Feb. 13), maintaining shareholder returns — modest yield (~0.5%) but supportive of income-focused holders. Hawkins, Inc. Declares Quarterly Cash Dividend of $0.19 Per Share
• Positive Sentiment: Analyst commentary highlights a long runway for acquisitions that could compound growth over time — a potential strategic catalyst if management executes M&A effectively. This is a longer‑term positive that won’t offset an earnings miss immediately. Hawkins Inc.: Long Runway Of Potential Acquisitions It Could Compound Well
• Neutral Sentiment: Company press release and slide deck provide the full Q3 results and management commentary (useful for evaluating margin drivers, segment details, and any outlook comments). Investors should review slides for cost, volume, or pricing details that could affect near-term performance. Hawkins, Inc. Reports Third-Quarter Fiscal 2026 Results
• Neutral Sentiment: Local earnings coverage summarizes the results and provides additional color; useful for a quick recap but adds little new information beyond the press release. Hawkins: Fiscal Q3 Earnings Snapshot
• Negative Sentiment: Quarterly results missed estimates: EPS $0.72 vs. $0.75 consensus and revenue $244.08M vs. $252.51M consensus — the misses likely prompted the intra‑day selloff as they directly hit near-term earnings expectations. Margin and ROE remain reasonable (net margin ~7.95%, ROE ~17.4%) but miss on top-line and EPS is the immediate negative driver. Hawkins (HWKN) Q3 Earnings and Revenues Miss Estimates

About Hawkins

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.